pain

News

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle

News

Trump signs legislation to tackle opiate addiction

President Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction to opiates in the US.

News

New US legislation aims to expedite development of non-opioi...

The US Senate looks set to pass a set of laws designed to tackle the country’s opioid crisis, encouraging research into non-addictive painkillers, as well as preventing opioids entering the

News

FDA approves Teva's higher-dose opioid dependence therapy

Cassipa is higher-dose version of Indivior's Suboxone

News

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer and Eli Lilly are competitors in NGF research

News

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

After years of delays Pfizer and Eli Lilly’s tanezumab non-opioid pain drug is edging closer to approval, after it met targets in an osteoarthritis trial.

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

Trump signs legislation to tackle opiate addiction

New US legislation aims to expedite development of non-opioi...

FDA approves Teva's higher-dose opioid dependence therapy

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer/Lilly non-opioid pain drug hits mark in phase 3 trial

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

pain

Editor's Picks